Cas no 1020718-66-4 (Minoxidil-d10)
Minoxidil-d10 Chemical and Physical Properties
Names and Identifiers
-
- MINOXIDIL-D10 (PIPERIDINE-D10)
- Minoxidil-d10
- ZFMITUMMTDLWHR-YXALHFAPSA-N
- 6-(1-Piperidinyl-d10)-2,4-pyriMidinediaMine 3-Oxide
- 2,4-DiaMino-6-(piperidino-d10) pyriMidine 3-N-Oxide
- 6-(1-PIPERIDINYL)-2,4-PYRIMIDINEDIAMINE-3-OXIDE-D10
- 6-(1-Piperidinyl-2,2,3,3,4,4,5,5,6,6-d10)-2,4-pyrimidinediamine 3-oxide
-
- Inchi: 1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2/i1D2,2D2,3D2,4D2,5D2
- InChI Key: ZIMGGGWCDYVHOY-YXALHFAPSA-N
- SMILES: ON1C(=N)N=C(C=C1N)N1C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H]
Computed Properties
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 1
- Complexity: 329
- XLogP3: 1.2
- Topological Polar Surface Area: 88.9
Experimental Properties
- Melting Point: 248-250°C
Minoxidil-d10 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M345002-0.5mg |
Minoxidil-d10 |
1020718-66-4 | 0.5mg |
$ 100.00 | 2023-02-02 | ||
| TRC | M345002-1mg |
Minoxidil-d10 |
1020718-66-4 | 1mg |
$ 176.00 | 2023-09-06 | ||
| TRC | M345002-5mg |
Minoxidil-d10 |
1020718-66-4 | 5mg |
$ 357.00 | 2023-04-16 | ||
| TRC | M345002-10mg |
Minoxidil-d10 |
1020718-66-4 | 10mg |
$ 534.00 | 2023-09-06 | ||
| TRC | M345002-25mg |
Minoxidil-d10 |
1020718-66-4 | 25mg |
$ 1062.00 | 2023-09-06 | ||
| A2B Chem LLC | AE10670-1mg |
MINOXIDIL-D10 |
1020718-66-4 | ≥99% deuterated forms (d1-d10) | 1mg |
$158.00 | 2024-04-20 | |
| A2B Chem LLC | AE10670-5mg |
MINOXIDIL-D10 |
1020718-66-4 | ≥99% deuterated forms (d1-d10) | 5mg |
$304.00 | 2024-04-20 | |
| A2B Chem LLC | AE10670-10mg |
MINOXIDIL-D10 |
1020718-66-4 | ≥99% deuterated forms (d1-d10) | 10mg |
$432.00 | 2024-04-20 | |
| ChemScence | CS-0062890-1mg |
Minoxidil-d10 |
1020718-66-4 | 1mg |
$190.0 | 2022-04-28 | ||
| ChemScence | CS-0062890-5mg |
Minoxidil-d10 |
1020718-66-4 | 5mg |
$550.0 | 2022-04-28 |
Minoxidil-d10 Related Literature
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
-
Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
-
Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
Additional information on Minoxidil-d10
Comprehensive Guide to Minoxidil-d10 (CAS No. 1020718-66-4): Properties, Applications, and Market Insights
Minoxidil-d10, with the CAS number 1020718-66-4, is a deuterated form of the well-known compound Minoxidil. This isotopic variant is increasingly gaining attention in pharmaceutical research and analytical chemistry due to its unique properties and applications. The compound is specifically designed for use as an internal standard in mass spectrometry, ensuring accurate quantification of Minoxidil in various biological matrices. Its molecular formula is C9H5D10N5O, and it features ten deuterium atoms replacing hydrogen atoms, which enhances its stability and detection sensitivity.
The primary application of Minoxidil-d10 lies in its role as a stable isotope-labeled internal standard. Researchers and pharmaceutical companies utilize it to improve the precision of Minoxidil quantification in pharmacokinetic studies, drug metabolism research, and quality control processes. The deuterium atoms in Minoxidil-d10 provide a distinct mass shift, enabling clear differentiation from the non-labeled compound during mass spectrometric analysis. This feature is particularly valuable in clinical trials and forensic toxicology, where accurate measurement of drug concentrations is critical.
In recent years, the demand for Minoxidil-d10 has surged, driven by the growing focus on hair loss treatments and dermatological research. Minoxidil, the parent compound, is widely recognized as a topical treatment for androgenetic alopecia (male and female pattern baldness). As a result, the deuterated version, Minoxidil-d10, plays a pivotal role in advancing research on drug delivery mechanisms, absorption rates, and metabolic pathways. This aligns with the increasing public interest in personalized medicine and precision dosing, making Minoxidil-d10 a hot topic in both scientific and consumer circles.
From a chemical perspective, Minoxidil-d10 exhibits high purity and stability, making it suitable for long-term storage and repeated use in laboratory settings. Its synthesis involves sophisticated techniques to ensure the precise incorporation of deuterium atoms, which is crucial for maintaining its isotopic integrity. The compound is typically supplied as a white to off-white powder, soluble in organic solvents like methanol and dimethyl sulfoxide (DMSO). These properties make it an indispensable tool for researchers aiming to achieve reproducible and reliable results in their studies.
The market for Minoxidil-d10 is expanding, with key players in the pharmaceutical and biotechnology industries investing heavily in deuterated compounds. The rise of generic drug development and bioequivalence studies has further fueled the demand for high-quality isotopic standards like Minoxidil-d10. Additionally, regulatory agencies such as the FDA and EMA emphasize the importance of accurate drug testing, which underscores the need for reliable reference materials. As a result, Minoxidil-d10 is increasingly featured in research publications and patent applications, highlighting its significance in modern drug development.
For those seeking to purchase Minoxidil-d10, it is essential to source the compound from reputable suppliers who provide detailed certificates of analysis (CoA) and ensure compliance with international quality standards. The compound's price can vary depending on purity levels and packaging specifications, but its value in research and development justifies the investment. Researchers are also encouraged to explore the latest advancements in deuterated pharmaceuticals, as this field continues to evolve with new applications and innovations.
In conclusion, Minoxidil-d10 (CAS No. 1020718-66-4) is a vital tool in pharmaceutical research, particularly in studies related to hair growth treatments and drug metabolism. Its unique isotopic properties, combined with its role as an internal standard, make it indispensable for achieving accurate and reproducible results. As the demand for precision medicine grows, Minoxidil-d10 is poised to remain a key player in advancing scientific understanding and therapeutic development. Whether you are a researcher, clinician, or industry professional, staying informed about the latest trends and applications of Minoxidil-d10 will be crucial for leveraging its full potential.
1020718-66-4 (Minoxidil-d10) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)